Publikationen von Sandra Scheuer

Ising, M.; Maccarrone, G.; Brueckl, T.; Scheuer, S.; Hennings, J.; Holsboer, F.; Turck, C. W.; Uhr, M.; Lucae, S.: FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20 (3), 485 (2019)

Scheuer, S.; Wiggert, N.; Brückl, T. M.; Awaloff, Y.; Uhr, M.; Lucae, S.; Kloiber, S.; Holsboer, F.; Ising, M.; Wilhelm, F. H.: Childhood abuse and depression in adulthood: The mediating role of allostatic load. PSYCHONEUROENDOCRINOLOGY 94, S. 134 - 142 (2018)

Breitenstein, B.; Scheuer, S.; Brückl, T. M.; Meyer, J.; Ising, M.; Uhr, M.; Holsboer, F.: Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study. JOURNAL OF PSYCHIATRIC RESEARCH 73, S. 86 - 95 (2016)

Scheuer, S.; Ising, M.; Uhr, M.; Otto, Y.; von Klitzing, K.; Klein, A. M.: FKBP5 polymorphisms moderate the influence of adverse life events on the risk of anxiety and depressive disorders in preschool children. JOURNAL OF PSYCHIATRIC RESEARCH 72, S. 30 - 36 (2016)

White, L. O.; Klein, A. M.; Kirschbaum, C.; Kurz-Adam, M.; Uhr, M.; Müller-Myhsok, B.; Hoffmann, K.; Sierau, S.; Michel, A.; Stalder, T. et al.; Horlich, J.; Keil, J.; Andreas, A.; Resch, L.; Binser, M. J.; Costa, A.; Giourges, E.; Neudecker, E.; Wolf, C.; Scheuer, S.; Ising, M.; von Klitzing, K.: Analyzing pathways from childhood maltreatment to internalizing symptoms and disorders in children and adolescents (AMIS): a study protocol. BMC PSYCHIATRY 15, 126 (2015)

Breitenstein, B.; Scheuer, S.; Holsboer, F.: Are there meaningful biomarkers of treatment response for depression? DRUG DISCOVERY TODAY 19 (5), S. 539 - 561 (2014)

Breitenstein, B.; Scheuer, S.; Pfister, H.; Uhr, M.; Lucae, S.; Holsboer, F.; Ising, M.; Brückl, T. M.: The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study. CNS SPECTRUMS 19 (2), S. 165 - 175 (2014)

Ising, M.; Scheuer, S.; Belcredi, P.; Uhr, M.; Holsboer, F.: Perspective of Personalized Drug Treatment in Depression. 73rd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), New York, NY, 10. Mai 2018 - 12. Mai 2018. BIOLOGICAL PSYCHIATRY 83 (9, Suppl.), S74, S. S375 - S376 (2018)

Ising, M.; Scheuer, S.; Belcredi, P.; Uhr, M.; Holsboer, F.: Perspective of personalised drug treatment in depression. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, S. S46 - S47. 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, SPAIN, 06. Oktober 2018 - 09. Oktober 2018. (2019)